Newsletter | December 22, 2022

12.22.22 -- FDA Accepts Biogen BLA For Biosimilar Actemra

Featured Editorial
Industry Insights
De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector

Discover how a biopharmaceutical company can de-risk the launch process by choosing a suitable autoinjector technology and partner.

CDMO Collaboration: Foundation For Sterile Injectable Product Success

Explore how a small or midsize biotech or pharma company developing sterile injectables can benefit from the experience and assistance provided by a CDMO.

Capture Of Bispecific Antibodies And Removal Of Product-Related Impurities

Many antibody variants are prone to aggregation or to forming product-related impurities. Explore the application of a resin with novel selectivity to purify challenging entities.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.